< 回列表
魏凌鴻
- Professor, Department of Obstetrics and Gynecology, Medical College, National Taiwan University, Taiwan
- Director of the Gynecologic Cancer Multidisciplinary Team of National Taiwan University Hospital, Taiwan
From Bench to Bedside: Translational Advances Shaping Diagnosis, Risk Stratification, and Precision Care in Gynecologic Oncology
| 角色 | 講師 |
| 日期時間 | 05/02 11:30 - 12:10 |
| 地點 | 701E |
學歷 / 訓練
2004, EMBA, College of Management, National Taiwan University
1999, PhD., , Laboratory of Molecular and Cellular Toxicology, Institute of Toxicology, College of Medicine, National Taiwan University
1986, M.D., Department of Medicine, College of Medicine, National Taiwan University
專業與研究經歷
2013 - 2016, Clinical Professor, Department of Obstetrics and Gynecology, Medical College, National Taiwan University
2007 - 2013, Clinical Associate Professo, Department of Obstetrics and Gynecology, Medical College, National Taiwan University
2005 - 2006, Visiting Scientist, PDT Center and Department of Molecular and Cellular Biology, Roswell Park Cancer Institute, USA
2002 - 2006, Clinical Assistant Professor, Department of Obstetrics and Gynecology, Medical College, National Taiwan University
2001 - 2016, Attending Physician, Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan
獲獎與榮譽
2023
The 75th Annual Congress of the Japan Society of Obstetrics and Gynecology (JSOG), International Session Award
2022
The 26th Taiwan Joint Cancer Conference (TJCC) Excellent Research Award
2016
The 21st Taiwan Joint Cancer Conference Excellent Research Award
2016
The 68th Annual Congress of the Japan Society of Obstetrics and Gynecology, International Session Award
2014
Taiwan Association of Obstetrics and Gynecology & Tzu-Yao Lee Foundation, Excellent Research Award
重要出版品
- TT Le, DY Wang, SR Yan, YC Chen, KC Chen, TZ Tan, PY Chu, DT Chen, YC Chiu, JY Sheu, CH Huang, J Ye, YT Tai, HF Juan, FC Tsai, WC Lin, YC Chiang, LH Wei and RY Huang. Spatial transcriptomic profiling of ovarian clear cell carcinoma reveals intra-tumor heterogeneity in OXPHOS and epithelial-mesenchymal gradients associated with clinical outcomes. Nature Communications 2026
- Lee KY, Chiang YC, Sheen JY, Yang AH, Lin YT, Wei LH, Sheu BC, Chang WC. Pembrolizumab combined with chemotherapy for advanced and recurrent endometrial cancer: A single-center retrospective study. J Formos Med Assoc. S0929-6646(25)00570-4, 2025
- Tai YT, Lin WC, Ye J, Chen DT, Chen KC, Wang DY, Tan TZ, Wei LH, Huang RY. Spatial Profiling of Ovarian Clear Cell Carcinoma Reveals Immune-Hot Features. Mod Pathol. 38(1):100630, 2024
- KJ Huang, WC Chang, CH Chen, WC Lin, WW Pan, HI Hsieh, YH Hsieh, LH Wei, BC Sheu Urine Protein to Creatinine Ratio for the Assessment of Bevacizumab-Associated Proteinuria in Patients with Gynecologic Cancers: A Diagnostic and Quality Improvement Study. Diagnostics (Basel).14(17):1852, 2024
- CJ Wu*, KF Pan*, JQ Chen, YC Tao, YC Liu, BR Chen, C Hsu, MY Wang, BC Sheu, M Hsiao, KT Hua, LH Wei Loss of LECT2 Promotes Ovarian Cancer Progression by Inducing Cancer Invasiveness and Facilitating an Immunosuppressive Environment. Oncogene 43(7):511-523, 2024